Phase 3 trial data confirm efficacy and safety profile of R21/Matrix-M malaria vaccine in African children Read more
SII seeks inclusion of COVID jab Covovax in CoWIN portal as heterologous booster dose for adults Read more
DCGI approves market authorisation for SII’s COVID vaccine Covovax as heterologous booster dose Read more